Report: Developing Opportunities within Weibo, AZZ, Air Industries Group, Moxian, Xtant Medical, and Brainstorm Cell Therapeutics — Future Expectations, Projections Moving into 2019


NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Weibo Corporation (NASDAQ:WB), AZZ Inc. (NYSE:AZZ), Air Industries Group (NYSE:AIRI), Moxian, Inc. (NASDAQ:MOXC), Xtant Medical Holdings, Inc. (NYSE:XTNT), and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

WB DOWNLOAD: http://MarketSourceResearch.com/register/?so=WB
AZZ DOWNLOAD: http://MarketSourceResearch.com/register/?so=AZZ
AIRI DOWNLOAD: http://MarketSourceResearch.com/register/?so=AIRI
MOXC DOWNLOAD: http://MarketSourceResearch.com/register/?so=MOXC
XTNT DOWNLOAD: http://MarketSourceResearch.com/register/?so=XTNT
BCLI DOWNLOAD: http://MarketSourceResearch.com/register/?so=BCLI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Weibo Corporation (NASDAQ:WB), AZZ Inc. (NYSE:AZZ), Air Industries Group (NYSE:AIRI), Moxian, Inc. (NASDAQ:MOXC), Xtant Medical Holdings, Inc. (NYSE:XTNT), and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

WEIBO CORPORATION (WB) REPORT OVERVIEW

Weibo's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Weibo reported revenue of $460.17MM vs $320.04MM (up 43.79%) and analysts estimated basic earnings per share $0.74 vs $0.46 (up 60.87%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Weibo reported revenue of $1,718.52MM vs $1,150.05MM (up 49.43%) and analysts estimated basic earnings per share $2.56 vs $1.60 (up 60.00%). Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.44. The estimated EPS forecast for the next fiscal year is $3.72 and is expected to report on March 3rd, 2020.

To read the full Weibo Corporation (WB) report, download it here: http://MarketSourceResearch.com/register/?so=WB

-----------------------------------------

AZZ INC. (AZZ) REPORT OVERVIEW

AZZ's Recent Financial Performance

For the three months ended November 30th, 2018 vs November 30th, 2017, AZZ reported revenue of $239.52MM vs $208.16MM (up 15.06%) and analysts estimated basic earnings per share $0.59 vs -$0.01. For the twelve months ended February 28th, 2018 vs February 28th, 2017, AZZ reported revenue of $810.43MM vs $863.54MM (down 6.15%) and analysts estimated basic earnings per share $1.74 vs $2.36 (down 26.27%). Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending February 28th, 2019. Reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $2.52 and is expected to report on May 21st, 2019.

To read the full AZZ Inc. (AZZ) report, download it here: http://MarketSourceResearch.com/register/?so=AZZ

-----------------------------------------

AIR INDUSTRIES GROUP (AIRI) REPORT OVERVIEW

Air Industries Group's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Air Industries Group reported revenue of $7.21MM vs $6.42MM (up 12.24%) and analysts estimated basic earnings per share -$0.26 vs -$0.97. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Air Industries Group reported revenue of $46.31MM vs $49.87MM (down 7.14%) and analysts estimated basic earnings per share -$0.41 vs -$1.70. Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is -$0.12 and is expected to report on April 16th, 2019.

To read the full Air Industries Group (AIRI) report, download it here: http://MarketSourceResearch.com/register/?so=AIRI

-----------------------------------------

MOXIAN, INC. (MOXC) REPORT OVERVIEW

Moxian's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Moxian reported revenue of $0.14MM vs $0.06MM (up 136.50%) and basic earnings per share $0.00 vs -$0.03. For the twelve months ended September 30th, 2018 vs September 30th, 2017, Moxian reported revenue of $0.34MM vs $0.09MM (up 268.66%) and analysts estimated basic earnings per share -$0.13 vs -$0.21. Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending March 31st, 2019.

To read the full Moxian, Inc. (MOXC) report, download it here: http://MarketSourceResearch.com/register/?so=MOXC

-----------------------------------------

XTANT MEDICAL HOLDINGS, INC. (XTNT) REPORT OVERVIEW

Xtant Medical's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Xtant Medical reported revenue of $18.26MM vs $19.33MM (down 5.53%) and analysts estimated basic earnings per share -$4.65 vs -$18.84. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Xtant Medical reported revenue of $72.20MM vs $82.61MM (down 12.60%) and analysts estimated basic earnings per share -$5.97 vs -$34.76. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019.

To read the full Xtant Medical Holdings, Inc. (XTNT) report, download it here: http://MarketSourceResearch.com/register/?so=XTNT

-----------------------------------------

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) REPORT OVERVIEW

Brainstorm Cell Therapeutics' Recent Financial Performance

Analysts expect earnings to be released on May 13th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.12. The estimated EPS forecast for the next fiscal year is -$0.26 and is expected to report on April 4th, 2019.

To read the full Brainstorm Cell Therapeutics Inc. (BCLI) report, download it here: http://MarketSourceResearch.com/register/?so=BCLI

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Jim Patterson, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.